GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Manuka Inc (OTCPK:MNKA) » Definitions » ROE %

Manuka (Manuka) ROE % : 0.00% (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Manuka ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Manuka's annualized net income for the quarter that ended in Sep. 2023 was $-0.51 Mil. Manuka's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $-1.37 Mil. Therefore, Manuka's annualized ROE % for the quarter that ended in Sep. 2023 was N/A%.

The historical rank and industry rank for Manuka's ROE % or its related term are showing as below:

MNKA's ROE % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 6.635
* Ranked among companies with meaningful ROE % only.

Manuka ROE % Historical Data

The historical data trend for Manuka's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manuka ROE % Chart

Manuka Annual Data
Trend
ROE %

Manuka Quarterly Data
Jun22 Sep22 Jun23 Sep23
ROE % - - - -

Competitive Comparison of Manuka's ROE %

For the Household & Personal Products subindustry, Manuka's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Manuka's ROE % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Manuka's ROE % distribution charts can be found below:

* The bar in red indicates where Manuka's ROE % falls into.



Manuka ROE % Calculation

Manuka's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Manuka's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-0.512/( (-1.344+-1.391)/ 2 )
=-0.512/-1.3675
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Manuka  (OTCPK:MNKA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.512/-1.3675
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.512 / 0.704)*(0.704 / 0.2125)*(0.2125 / -1.3675)
=Net Margin %*Asset Turnover*Equity Multiplier
=-72.73 %*3.3129*N/A
=ROA %*Equity Multiplier
=-240.95 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.512/-1.3675
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.512 / -0.512) * (-0.512 / -0.612) * (-0.612 / 0.704) * (0.704 / 0.2125) * (0.2125 / -1.3675)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.8366 * -86.93 % * 3.3129 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Manuka ROE % Related Terms

Thank you for viewing the detailed overview of Manuka's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Manuka (Manuka) Business Description

Traded in Other Exchanges
N/A
Address
3 Eliezer Vardinon Street, Petach Tikva, ISR, 4959507
Manuka Inc is a beauty company that develops and distributes premium-quality skincare products, that are based on M?nuka honey and bee venom. Its skincare products are manufactured in Israel by its vendor, Chic with M?nuka honey ingredients. The company imports Manuka honey from its supplier in New Zealand, Waitemata Honey pursuant to the Supply Agreement. Currently, it operates only in Israel through the online platform. Its website and mobile applications currently offer six cosmetic skincare products: Face Serum with Manuka Honey and Bee Venom; Face Serum with enhanced Vitamin C; Day Cream; Night nourishing Cream; Eye Cream; and Face Cleanser Gel.
Executives
David Dana officer: Chief Financial Officer 3 ELIEZER VARDINON ST., PETACH TIKVA L3 4959507
Shimon Citron director, officer: Chief Executive Officer
Brian M Culley officer: Chief Executive Officer 6725 MESA RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
Peter N. Payne officer: Chief Executive Officer C/O NEW YORK GLOBAL INNOVATIONS INC., 18 E. 16TH STREET, SUITE 307, NEW YORK NY 10003
Dana Wolf officer: Chief Scientific Officer 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Tonak Ltd. 10 percent owner 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Israel Alfassi director 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Chanan Morris officer: Chief Financial Officer 30 HAKTORET STREET, EFRAT L3 90435
Arias Roberto Alonso Jimenez director C/O NEW YORK GLOBAL INNOVATIONS INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
Tomer Assis officer: Chief Financial Officer C/O INKSURE TECHNOLOGIES INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
David W Sass director, officer: Secretary 260 MADISON AVE 18TH FLR, NEW YORK NY 10016
David Avner officer: CHIEF FINANCIAL OFFICER 1 HAMADA ST, REHOVOT L3 76703
Jonathan Bettsak director C/O INKSURE LTD 1 HAMADA ST., THE RABIN SCIENCE PARK, REHOVOT L3 76703
Tal Gilat officer: President and CEO C/O INKSURE, 1 HAMADA ST., REHOVOT L3 76703
Alon Raich director C/O ICTS INTERNATIONAL, N.V., BIESBOSCH 225, 1181 JC AMSTELVEEN P7 0000000000

Manuka (Manuka) Headlines

No Headlines